Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly
diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are …

DNA damage and repair studies are at the core of the radiation biology field and represent
also the fundamental principles informing radiation therapy (RT). DNA damage levels are a …

Purpose To assess hypo-fractionated particle beam therapy (PBT)'s efficacy relative to that
of photon stereotactic body radiotherapy (SBRT) for early stage (ES) non-small cell lung …

Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures …

BACKGROUND The authors evaluated the efficacy, patterns of failure, and toxicity of
stereotactic ablative radiotherapy (SABR) for patients with medically inoperable, clinical …

Introduction The risk for development of a second primary lung cancer (SPLC) after
treatment of an initial primary lung cancer (IPLC) is around 1% to 2% per patient per year …

Background: Stereotactic body radiotherapy (SBRT) has been adopted as the standard of
care for inoperable early-stage non-small cell lung cancer (NSCLC), with local control rates …

Purpose To investigate whether imaging features from pretreatment planning CT scans are
associated with overall survival (OS), recurrence‐free survival (RFS), and loco‐regional …

Radiotherapy is still a treatment of choice for many malignancies, often in combination with
other strategies. However, its efficacy is limited by the dose that can be safely administered …

Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable,
early-stage non–small-cell lung cancer. SABR results in high rates of in-field tumor control …